Surgery Websites
Department of Surgery »  Faculty »  Adult Cardiothoracic Surgery »  Arthur Hill, M.D.
Arthur Hill, M.D.

Arthur Hill, M.D.

Professor of Surgery
Division of Adult Cardiothoracic Surgery

Contact Information

Academic Office:
505 Parnassus Ave- MUW 405, Box 0118
San Francisco, CA 94143
tel: (415) 353-8196
fax: (415) 353-4716
Zuckerberg San Francisco General Hospital
1001 Potrero Ave, Ward 3A, Box 0807
San Francisco, CA  94110
tel: (415) 206-4622
fax: (415) 206-5484
appt:(415) 206-8673
Open Popup
  • Tufts University School of Medicine, M.D., 1982
  • University of California, Los Angeles, Intern Surgery, 1982-1983
  • University of California, Los Angeles, Resident General Surgery, 1983-1988
  • Stanford University Medical Center, Chief Resident Non-Cardiac Thoracic Surgery, 1991
  • The Cleveland Clinic Foundation Cardiothoracic Surgery, Associate Staff, 1991-1992
  • Cardiovascular Research Institute, University of California, San Francisco, Postdoctoral Fellow Cardiovascular Research, 1984-1986
  • Stanford University Medical Center, Resident, Cardiovascular Surgery, 1988-1990
  • Stanford University Medical Center, Fellow, Cardiopulmonary Transplantation, 1990
  • American Board of Surgery
  • American Board of Surgery, Subspecialty Surgical Critical Care
  • American Board of Thoracic Surgery
  • UCSF Department of Surgery at UCSF Medical Center
  • UCSF Department of Surgery at Zuckerberg SFGH
  • Anastomotic technology for use in minimally invasive and robotic CABG
  • Medical uses of Nitinol
  • Nitinol for aortic, mitral and tricuspid repair and replacement
  • PLAATO Left Atrial Appendage Occlusion Device for Treatment of Atrial Fibrillation
  • Sealant, Super-sealant, and hemostatic devices used in Surgery
  • Vascular peptide coating to promote endothelial adhesion and proliferation
  • Pre-clinical and clinical development of new medical technology including:

Dr. Arthur Hill is Professor of Clinical Surgery and Chief of Thoracic Surgery at Zuckerberg San Francisco General Hospital.  Dr. Hill has been on the faculty since 2000. Dr. Hill is a graduate of Tufts University School of Medicine.  He completed his General Surgery Residency at the UCLA School of Medicine and his  training in Cardiovascular Surgery, Cardiothoracic Surgery and Cardiopulmonary Transplantation at Stanford University. Dr. Hill's area of clinical expertise is in Cardiothoracic Surgery.

Dr. Hill is certified by the American Board of Surgery, the American Board of Thoracic Surgery, and the American Board of Surgical Critical Care. His clinical interest include general thoracic, cardiac and thoracic trauma surgery. Dr. Hill is a fellow of the American College of Cardiology, American College of Surgeons, American College of Chest Physicians, and a member of the International Society for Heart and Lung Transplantation, American Heart Association, California Medical Association, and the American Medical Association.



  1. Hill AC, Maroney TP, Virmani R. Facilitated coronary anastomosis using a nitinol U-Clip device: bovine model. J Thorac Cardiovasc Surg. 121: 859-70, May/2001. This is a pre-clinical study of the efficacy of the Nitinol U-clip for coronary anastomosis in calves, and was compared to sutured coronary anastomosis. A. Hill designed the study, performed coronary and jugular anastomoses in all animals, presented the paper at the American Association of Thoracic Surgeons meeting, and wrote the paper.
  2. Wolf RK, Alderman EL, Caskey MP, Raczkowski AR, Dullum MK, Lundell DC, Hill AC, Wang N, Daniel MA. Clinical and six-month angiographic evaluation of coronary arterial graft interrupted anastomoses by use of a self-closing clip device: a multicenter prospective clinical trial. J Thorac Cardiovasc Surg. 26: 168-77; discussion 177-8, Jul/2003. This is the clinical study that evolved from the pre-clinical studies that were performed in calves. A. Hill designed the clinical study and was Principal Investigator. (First authorship was awarded to the investigators with the highest volume of cases). This device was FDA approved and is currently marketed by Medtronic Inc. A. Hill is named in patents related to this device.
  3. Fjellbirkeland L, Canbier S, Hill AC, Broaddus VC, Brunetta P, ten Dijke P, Dolganov G, Jablons D, Nishimura SL. Integrin-mediated Activation of TGF-ß Inhibits Human Airway Proliferation in situ. Am J Path. 533-42, 08/2003. A. Hill participated in specimen collection, data analysis, and co-wrote the paper.
  4. Li C, Hill AC, Imran I. Peptide-coated Vascular Grafts: An in vivo Study in Sheep. Hemodialysis International. 365-372, 2004. This is a sheep study comparing peptide coated vascular prosthesis versus uncoated vascular prosthetic material and simulating dialysis access grafts. A. Hill designed the animal study, performed the surgical procedures in all of the sheep, performed data collection and analysis, and co-wrote the paper.
  5. Li, C, Hill AC, Imran M. In vitro and in vivo studies of ePTFE vascular grafts treated with P15 peptide. Journal of Biomaterials Science. Polymer Edition Ed vol. 16: 875-891(17), 07/2005. This study compared the data obtained from in vitro analysis of peptide coated prosthetic grafts to in vivo studies of peptide coated vascular grafts. A. Hill designed the in vivo studies and performed the graft implants. A. Hill performed in vivo data analysis and co-wrote the paper. C. Li is a polymer biochemist who developed the preparation and methodology for P15 peptide coating.


Site Directory